COSMOS Pharmaceutical Corporation (CSMYF) Stock Price & Growth Analysis

Quote Panel

Updated October 22, 2025

1W 0.00 % 1M 0.00 % 3M 0.00 % 1Y 18.50 %

Key Metrics

Market Cap
3.65B
Shares Outstanding
79.26M
Share in Float
43.82M
Dividende
0.47451

Earning Date
09 Jan 2026
Price Target
46.06
Average Volume
4.43548
Beta
0.223

Range
39.3-61.39
Industry
Medical - Pharmaceuticals
Website
https://www.cosmospc.co.jp
Sector
Healthcare

Quote Panel

Updated October 22, 2025

1W % 1M % 3M % 1Y %

Key Metrics

Market Cap
Shares Outstanding
Share in Float
Dividende

Earning Date
No Data
Price Target
Average Volume
Beta

Range
Industry
Website
Sector

Fundamentals

18.70x

P/E Ratio

0.58x

P/S Ratio

2.27x

P/B Ratio

0.2

Debt/Equity

3.1%

Net Margin

$2.3

EPS

How CSMYF compares to sector?

P/E Ratio

Fundamentals

Relative Strength

CSMYF

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Relative Strength

CSMYF

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

$1045B

324%

2026-Revenue

$402.54

303%

2026-EPS

$63B

295%

2026-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Buy

Price Target

N/A(N/A)

Number of analyst

N/A

Last analyst upgrade/downgrade

Macquarie

upgrade

Previous: Not converted

2024-10-15

Now: Neutral

Jefferies

initialise

Previous: Not converted

2024-08-15

Now: Buy

Forecast

Analyst rating

Last analyst upgrade/downgrade

Earnings Growth

YoY

Current

Estimates

Q2.23

-99%

1.36
vs 169.2

Q3.23

-99%

1.13
vs 163.67

Q4.23

-99%

0.87
vs 121.67

Q1.24

+5%

0.97
vs 0.92

Q2.24

-58%

0.57
vs 1.36

Q3.24

-38%

0.7
vs 1.13

Q4.24

-39%

0.53
vs 0.87

Q1.25

-32%

0.66
vs 0.97

Q2.25

+19584%

112
vs 0.57

Q3.25

+15840%

111.9
vs 0.7

Sales Growth

YoY

Current

Estimates

Q2.23

+13%

221.4B vs 196.5B

Q3.23

+17%

241.7B vs 206.1B

Q4.23

+19%

234.8B vs 197.9B

Q1.24

+18%

238.9B vs 202.3B

Q2.24

+13%

249.7B vs 221.4B

Q3.24

+8%

261.8B vs 241.7B

Q4.24

+4%

244.1B vs 234.8B

Q1.25

+3%

246.3B vs 238.9B

Q2.25

+3%

257.4B vs 249.7B

Q3.25

+5%

274.4B vs 261.8B

Return on Equity

QoQ

Q1.23

+2%

0.02
vs 0.02

Q2.23

+4%

0.04
vs 0.02

Q3.23

+3%

0.03
vs 0.04

Q4.23

+2%

0.02
vs 0.03

Q1.24

+3%

0.03
vs 0.02

Q2.24

+3%

0.03
vs 0.03

Q3.24

+3%

0.03
vs 0.03

Q4.24

+3%

0.03
vs 0.03

Q1.25

+3%

0.03
vs 0.03

Q2.25

+3%

0.03
vs 0.03

Institutionnal Ownership

N/A

Q3.23

NA
vs NA

Q4.23

NA
vs NA

Q1.24

NA
vs NA

Q2.24

NA
vs NA

Q3.24

NA
vs NA

Q4.24

NA
vs NA

Q1.25

NA
vs NA

Q2.25

NA
vs NA

Q3.25

NA
vs NA

Q4.25

NA
vs NA

Company Description